BRAINSTORM CELL THERAPEUTICS INC. (Nasdaq:BCLI)
N/A • N/A
CIK 1137883
Company
N/A
Address
N/A
N/A
Employees
None
None
Key Executives
Board Of Directors
SEC filings
Date | Form | Event |
---|---|---|
14 Nov, 2024 | 8-K | |
14 Nov, 2024 | SC 13G | |
14 Nov, 2024 | 10-Q | |
13 Nov, 2024 | SC 13G | |
30 Oct, 2024 | 8-K | |
2 Oct, 2024 | 4 | |
1 Oct, 2024 | 8-K | |
1 Oct, 2024 | 8-K | |
27 Sep, 2024 | EFFECT | |
26 Sep, 2024 | 8-K | |
26 Sep, 2024 | CORRESP | |
24 Sep, 2024 | S-3/A | |
24 Sep, 2024 | CORRESP | |
20 Sep, 2024 | UPLOAD | |
17 Sep, 2024 | S-3 | |
16 Sep, 2024 | 8-K | |
6 Sep, 2024 | EFFECT | |
4 Sep, 2024 | CORRESP | |
3 Sep, 2024 | UPLOAD | |
28 Aug, 2024 | S-3 | |
16 Aug, 2024 | DEF 14A | |
16 Aug, 2024 | ARS | |
14 Aug, 2024 | 8-K | |
14 Aug, 2024 | 10-Q | |
6 Aug, 2024 | PRER14A | |
5 Aug, 2024 | PRE 14A | |
31 Jul, 2024 | 4/A | |
31 Jul, 2024 | 4/A | |
31 Jul, 2024 | 4/A | |
31 Jul, 2024 | 4/A | |
31 Jul, 2024 | 4/A | |
31 Jul, 2024 | 4/A | |
31 Jul, 2024 | 4/A | |
30 Jul, 2024 | 8-K | |
24 Jul, 2024 | 4 | |
19 Jul, 2024 | 8-K | |
28 Jun, 2024 | 8-K | |
28 Jun, 2024 | 424B5 | |
27 Jun, 2024 | 424B5 | |
26 Jun, 2024 | 8-K | |
25 Jun, 2024 | 4 | |
25 Jun, 2024 | 3 | |
20 Jun, 2024 | 8-K | |
4 Jun, 2024 | 8-K | |
3 Jun, 2024 | 4 | |
23 May, 2024 | 4 | |
14 May, 2024 | 10-Q | |
14 May, 2024 | 4 | |
7 May, 2024 | 4 | |
7 May, 2024 | 4 | |
3 May, 2024 | 8-K | |
25 Apr, 2024 | 4 | |
22 Apr, 2024 | 3 | |
19 Apr, 2024 | 4 | |
17 Apr, 2024 | 8-K | CEO Change |
11 Apr, 2024 | 8-K | |
9 Apr, 2024 | 8-K | |
2 Apr, 2024 | 8-K | |
2 Apr, 2024 | 424B5 | |
1 Apr, 2024 | 8-K | |
1 Apr, 2024 | 10-K | |
13 Mar, 2024 | 4 | |
13 Mar, 2024 | 4 | |
13 Mar, 2024 | 4 | |
13 Mar, 2024 | 4 | |
12 Feb, 2024 | SC 13G/A | |
20 Dec, 2023 | 8-K | |
22 Nov, 2023 | DEFA14A | |
22 Nov, 2023 | 8-K | |
14 Nov, 2023 | 8-K | |
14 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
8 Nov, 2023 | DEF 14A | |
3 Nov, 2023 | 8-K | |
24 Oct, 2023 | 8-K | |
5 Sep, 2023 | 4 | |
14 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
7 Aug, 2023 | 4 | |
4 Aug, 2023 | 4 | |
19 Jul, 2023 | 8-K | |
19 Jul, 2023 | 424B5 | |
21 Jun, 2023 | 4 | |
21 Jun, 2023 | 3 | |
6 Jun, 2023 | 8-K | |
24 May, 2023 | 8-K | |
15 May, 2023 | 8-K | |
15 May, 2023 | 10-Q | |
1 May, 2023 | 3 | |
1 May, 2023 | 4 | |
24 Apr, 2023 | 4 | |
24 Apr, 2023 | 4 | |
5 Apr, 2023 | SC 13G/A | |
30 Mar, 2023 | 10-K | |
30 Mar, 2023 | 8-K | |
27 Mar, 2023 | 8-K | |
11 Jan, 2023 | 8-K | |
4 Jan, 2023 | 8-K | |
4 Jan, 2023 | 4 | |
4 Jan, 2023 | 4 | |
13 Dec, 2022 | DEF 14A | |
14 Nov, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
12 Oct, 2022 | 8-K | |
22 Sep, 2022 | 8-K | |
15 Aug, 2022 | 10-Q | |
15 Aug, 2022 | 8-K | |
16 May, 2022 | 10-Q | |
16 May, 2022 | 8-K | |
8 Apr, 2022 | 4 | |
28 Mar, 2022 | 8-K | |
28 Mar, 2022 | 10-K | |
14 Mar, 2022 | 4 | |
14 Feb, 2022 | SC 13G | |
4 Feb, 2022 | SC 13G | |
3 Feb, 2022 | 4 | |
28 Jan, 2022 | 8-K | |
17 Dec, 2021 | 4 | |
17 Dec, 2021 | 4 | |
17 Dec, 2021 | 4 | |
17 Dec, 2021 | 4 | |
17 Dec, 2021 | 4 | |
17 Dec, 2021 | 8-K | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | S-8 | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
15 Nov, 2021 | 10-Q | |
4 Nov, 2021 | 3 | |
4 Nov, 2021 | DEF 14A | |
29 Oct, 2021 | 8-K | |
2 Sep, 2021 | 3 | |
25 Aug, 2021 | 8-K | |
19 Aug, 2021 | EFFECT | |
17 Aug, 2021 | CORRESP | |
16 Aug, 2021 | UPLOAD | |
13 Aug, 2021 | 8-K | |
9 Aug, 2021 | S-3 | |
5 Aug, 2021 | 8-K | |
5 Aug, 2021 | 10-Q | |
12 Jul, 2021 | SC 13G/A | |
28 May, 2021 | 8-K | |
26 Apr, 2021 | 8-K | |
26 Apr, 2021 | 10-Q | |
4 Feb, 2021 | 8-K | |
4 Feb, 2021 | 10-K | |
2 Feb, 2021 | SC 13G |
We don't have more information about this company at this moment.
Last update:None
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.